Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02407509 |
Title | Phase I Trial of RO5126766 Alone and in Combination With Everolimus (RAF/MEK) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Royal Marsden NHS Foundation Trust |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries |